Skip to main content
Article thumbnail
Location of Repository

Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination

By Grant Austin Mackenzie, Jonathan Rhys Carapetis, Amanda Jane Leach and Peter Stanley Morris
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2003). A: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
  2. (2007). A: Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA
  3. (2008). A: The burden of hospitalised, radiologically diagnosed pneumonia
  4. (1996). Australian Bureau of Statistics: ABS Website.
  5. (2004). AW: Prevalence of chronic suppurative otitis media among the children living in two selected slums in Dhaka City. Bangladesh Med Res Counc Bull
  6. (2006). Chronic suppurative otitis media in Tanzanian school children and its effects on hearing. East Afr Med J
  7. (2008). Compared to placebo, longterm antibiotics resolve otitis media with effusion and prevent acute otitis media with perforation in a high-risk population: a randomized double-blind placebo controlled trial. BMC Pediatrics
  8. (2005). de: Chronic suppurative otitis media and related complications at the University Clinic of Kinshasa.
  9. (2004). E: Community-wide vaccination with heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J
  10. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J
  11. (2007). Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA
  12. (2005). ER: Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis
  13. (2006). Fritzell B: Brief review of the clinical effectiveness of PREVENAR(R) against otitis media. Vaccine
  14. (2007). Hanage WP: Emergence of 19A as a virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J
  15. (2007). Health of Aboriginal and Torres Strait Islander children in remote Far North Queensland: findings of the Paediatric Outreach Service. MJA
  16. (2005). Ijadunola IK, Onayade OO: Epidemiology of otitis media in a local tropical African population.
  17. (2008). Immunogenicity for 16 serotypes of a unique schedule of pneumococal vaccines in a high-risk population. Vaccine
  18. (2003). Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J
  19. (1994). JD: Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr Infect Dis J
  20. (2006). L: Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet
  21. (2005). Microbiology of acute otitis media with perforation (AOMwiP) in Aboriginal children living in remote communities – monitoring the impact of 7-valent pneumococcal conjugate vaccine (7vPCV). In Streptococci: New Insights into an Old Enemy:
  22. (2007). MR: Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics
  23. (2005). Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross sectional survey. BMC Pediatrics
  24. (2001). PH: Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
  25. (2004). Pichichero ME: Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J
  26. (1996). Prevention of hearing impairment from chronic otitis media. Presented at a WHO/CIBA Foundation Workshop.
  27. (1996). Prospective studies of respiratory pathogens, particularly Streptococcus pneumoniae, in Aboriginal and nonAboriginal infants: impact of antibiotic use and implications for otitis media. In
  28. (2008). Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants. Pediatr Infect Dis J
  29. (2003). The WHO Pneumococcal Vaccine Trials Carriage Working Group: Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J
  30. (2004). TM: The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J
  31. Wyeth product pipeline: Wyeth website [ h t t p : / /] Pre-publication history The pre-publication history for this paper can be accessed here:

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.